Dennis Brown
Chairman presso CELL SOURCE, INC.
Patrimonio netto: 89 395 $ in data 31/03/2024
Profilo
Dennis M.
Brown is the founder of ChemGenex Therapeutics, Inc. (founded in 1999), Matrix Pharmaceutical, Inc. (founded in 1985), Kintara Therapeutics, Inc. (founded in 2009), Mountain View Pharmaceuticals, Inc. (founded in 2000), and Del Mar Pharmaceuticals (BC) Ltd.
(founded in 2010).
His current job(s) include Chairman at Cell Source, Inc. (since 2014), Director at Rakovina Therapeutics, Inc. (since 2021), Director at Azora Therapeutics, Inc., Director at Medasystems, Inc., Member-Research Roundtable at National Brain Tumor Society, Inc., and President at Valent Technologies LLC (since 2020).
His former job(s) include President & Executive Director at ChemGenex Pharmaceuticals Pty Ltd.
(2004-2009), Managing Director at EGB Ventures LLC, Director at NewGen Therapeutics, Inc., Assistant Professor at Harvard Medical School, and Associate at Stanford University School of Medicine.
He obtained his undergraduate degree from New York University in 1971 and his graduate and doctorate degrees from New York University in 1975 and 1979, respectively.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/08/2023 | 625 000 ( 0.96% ) | 46 250 $ | 31/03/2024 | |
CELL SOURCE, INC.
0.34% | 01/08/2023 | 129 929 ( 0.34% ) | 40 408 $ | 31/03/2024 |
CELL SOURCE, INC.
inf% | 01/08/2023 | 6 667 ( inf% ) | 2 073 $ | 31/03/2024 |
| 14/09/2023 | 6 377 ( 0.02% ) | 663 $ | 31/03/2024 |
Posizioni attive di Dennis Brown
| Società | Posizione | Inizio |
|---|---|---|
| CELL SOURCE, INC. | Chairman | 19/08/2015 |
| RAKOVINA THERAPEUTICS INC. | Director/Board Member | 25/03/2021 |
Medasystems, Inc.
 Medasystems, Inc. Packaged SoftwareTechnology Services Medasystems, Inc. is a software development company based in Menlo Park, CA. Medasystems specializes in developing software that streamlines the handling of requests for experimental therapies from healthcare providers. The company's secure and GXP compliant application acts as a centralized environment, connecting physicians and pharmaceutical companies to facilitate patient access to investigational therapies. The platform streamlines physician inquiries to life science companies for investigational medicine, including expanded access or compassionate use, post-trial access, and investigator-initiated studies. Medasystems provides pharmaceutical manufacturers with software and tools to streamline expanded access or compassionate use requests, as well as the evaluation of IIS or IST proposals, and the management of post-trial access. Medasystems, Inc. was founded by Jeffrey Thibeault, Matthew Rosen, and John Langlands. Fiona Smythe has been the CEO of the company since 2021. | Director/Board Member | - |
Azora Therapeutics, Inc.
 Azora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azora Therapeutics, Inc. is a clinical stage biopharmaceutical company that develops novel small molecule chemical entities for the treatment of autoimmune and auto-inflammatory diseases. The company is based in Encino, CA. Azora Therapeutics was founded by Matthew Davidson and Julie Saiki, with Matthew Davidson serving as the CEO since incorporation. | Director/Board Member | - |
National Brain Tumor Society, Inc.
 National Brain Tumor Society, Inc. Miscellaneous Commercial ServicesCommercial Services National Brain Tumor Society, Inc. operates a foundation focused on brain tumor treatment. The company was founded by G. Bonnie Feldman in 2008 and is headquartered in Newton, MA. | Corporate Officer/Principal | - |
| Valent Technologies LLC | President | 01/03/2020 |
Mountain View Pharmaceuticals, Inc.
 Mountain View Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mountain View Pharmaceuticals, Inc. manufactures bio-pharmaceutical drugs. The American company was founded by Merry R. Sherman, Dennis M. Brown. Merry R. Sherman has been the CEO since incorporation. | Founder | 01/01/2000 |
Del Mar Pharmaceuticals (BC) Ltd.
 Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Part of Kintara Therapeutics, Inc., Del Mar Pharmaceuticals (BC) Ltd. provides drug development services. The private company is based in Vancouver, Canada. The Canadian company was founded by William James Garner, Jeffrey A. Bacha, Dennis M. Brown. Jeffrey A. Bacha has been the CEO since incorporation. Del Mar Pharmaceuticals (BC was acquired by Kintara Therapeutics, Inc. on January 25, 2013 for $0.65 million. | Founder | 02/04/2010 |
Precedenti posizioni note di Dennis Brown
| Società | Posizione | Fine |
|---|---|---|
| KINTARA THERAPEUTICS, INC. | Founder | 20/11/2023 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Formazione di Dennis Brown
| New York University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| KINTARA THERAPEUTICS, INC. | Health Technology |
| RAKOVINA THERAPEUTICS INC. | Finance |
| Aziende private | 12 |
|---|---|
Matrix Pharmaceutical, Inc.
 Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Health Technology |
| Cell Source, Inc. | |
ChemGenex Pharmaceuticals Pty Ltd.
 ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals Pty Ltd. develops pharmaceutical products. It develops small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs. The firm also develops personalized oncology, obesity and diabetes medicines. The company was founded in September 1958 and is headquartered in Geelong, Australia. | Health Technology |
Mountain View Pharmaceuticals, Inc.
Mountain View Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mountain View Pharmaceuticals, Inc. manufactures bio-pharmaceutical drugs. The American company was founded by Merry R. Sherman, Dennis M. Brown. Merry R. Sherman has been the CEO since incorporation. | Health Technology |
EGB Ventures LLC
 EGB Ventures LLC Investment ManagersFinance EGB Ventures LLC EGB Ventures) is a venture capital firm founded in 2010 by William (Bill) Garner. The firm is headquartered in Whitewright, Texas. | Finance |
National Brain Tumor Society, Inc.
National Brain Tumor Society, Inc. Miscellaneous Commercial ServicesCommercial Services National Brain Tumor Society, Inc. operates a foundation focused on brain tumor treatment. The company was founded by G. Bonnie Feldman in 2008 and is headquartered in Newton, MA. | Commercial Services |
Del Mar Pharmaceuticals (BC) Ltd.
Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Part of Kintara Therapeutics, Inc., Del Mar Pharmaceuticals (BC) Ltd. provides drug development services. The private company is based in Vancouver, Canada. The Canadian company was founded by William James Garner, Jeffrey A. Bacha, Dennis M. Brown. Jeffrey A. Bacha has been the CEO since incorporation. Del Mar Pharmaceuticals (BC was acquired by Kintara Therapeutics, Inc. on January 25, 2013 for $0.65 million. | Health Technology |
| ChemGenex Therapeutics, Inc. | |
NewGen Therapeutics, Inc.
 NewGen Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology NewGen Therapeutics, Inc. engages in the provision of research and development services. The company is headquartered in Menlo Park, CA. | Health Technology |
Azora Therapeutics, Inc.
Azora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azora Therapeutics, Inc. is a clinical stage biopharmaceutical company that develops novel small molecule chemical entities for the treatment of autoimmune and auto-inflammatory diseases. The company is based in Encino, CA. Azora Therapeutics was founded by Matthew Davidson and Julie Saiki, with Matthew Davidson serving as the CEO since incorporation. | Health Technology |
Medasystems, Inc.
Medasystems, Inc. Packaged SoftwareTechnology Services Medasystems, Inc. is a software development company based in Menlo Park, CA. Medasystems specializes in developing software that streamlines the handling of requests for experimental therapies from healthcare providers. The company's secure and GXP compliant application acts as a centralized environment, connecting physicians and pharmaceutical companies to facilitate patient access to investigational therapies. The platform streamlines physician inquiries to life science companies for investigational medicine, including expanded access or compassionate use, post-trial access, and investigator-initiated studies. Medasystems provides pharmaceutical manufacturers with software and tools to streamline expanded access or compassionate use requests, as well as the evaluation of IIS or IST proposals, and the management of post-trial access. Medasystems, Inc. was founded by Jeffrey Thibeault, Matthew Rosen, and John Langlands. Fiona Smythe has been the CEO of the company since 2021. | Technology Services |
| Valent Technologies LLC |
- Borsa valori
- Insiders
- Dennis Brown
